Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2179087Generated: November 1, 2026

5-(chloromethyl)-1-cyclopropyl-1H-1,2,3,4-tetrazole → (2S,3S)-1-[5-tert-Butyl-2-(1-cyclopropyl-1H-tetrazol-5-ylmethyl)-2H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl]-2-hydroxymethyl-pyrrolidin-3-ol

https://huagongshe.com/reaction/2179087

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-(chloromethyl)-1-cyclopropyl-1H-1,2,3,4-tetrazoleHCID 25524499—
Reactant5-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-2-ethyl-2H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 71576307—
ReactantHCID 178441792HCID 178441792—
SolventMethanolHCID 887—
Product(2S,3S)-1-[5-tert-Butyl-2-(1-cyclopropyl-1H-tetrazol-5-ylmethyl)-2H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl]-2-hydroxymethyl-pyrrolidin-3-olHCID 89586566—

Reaction Steps

In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-2-ethyl-2H-[1,2,3]triazolo[4,5-d]pyrimidine (example 3, step b), the title compound was prepared from Trifluoro-acetic acid (2S,3S)-1-(5-tert-butyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)-2-(2,2,2-trifluoro-acetoxymethyl)-pyrrolidin-3-yl ester and 5-(chloromethyl)-1-cyclopropyl-1H-tetrazole. After completion of the substitution reaction methanol was added and the mixture was stirred for 1 h at room temperature and subsequently subjected to purification with preparative HPLC on reversed phase eluting with a gradient formed from acetonitrile, water and NEt3. After evaporation of the product containing fractions the title compound was isolated as light-yellow solid. MS (m/e): 415.4 (MH+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09067943B2
Source datasetuspto-grants-2015_06
ORD IDord-969010256d7342378f2e4680afefcaaa
Source noteuspto-grants-2015_06